Eye Area Surgery and Medical Aesthetic Services

Ultrasound-assisted filler dissolution: what should be assessed first?

Filler dissolution aims to reduce hyaluronic acid filler using the enzyme hyaluronidase. It is not a universal reversal for every injectable material. The original product, its location and the reason for concern matter before choosing another procedure. Ultrasound may help the assessment, but does not make an injection risk-free.

Consultation information

Editorial illustration; not evidence of a diagnosis, treatment outcome or individual plan.

On this page

The first distinction: planned correction or urgent complication?

A stable concern about shape is different from a new medical problem. During or shortly after filler treatment, unusual pain, white or blue-grey skin, or a change in vision requires immediate medical help. Do not wait for a cosmetic consultation or an ultrasound appointment. Tell the emergency team about the injection and its timing. F1

What the product history changes

Information available	What to discuss
Confirmed hyaluronic acid filler	Whether reducing that filler addresses the actual concern. F2
Another filler or permanent material	Hyaluronidase cannot be assumed to remove it; specialist assessment may lead to other options. F1
Product unknown	Bring any treatment record; uncertainty needs to remain part of the plan. B1

Bring the product name, treatment date and area, any previous dissolving procedures, and a timeline of symptoms. Mention previous reactions, allergies and current medicines. Old photographs can help explain what changed, but are not a diagnosis. B1 F4

What ultrasound can and cannot do

In selected cases, ultrasound can help assess filler location and guide the clinician's intervention. Published studies include retrospective case series of vascular complications; their results do not promise the same outcome for elective correction or every anatomical area. Imaging does not establish that every lump or swelling is simply excess filler. B1 F3

Ask what the scan is intended to clarify, whether it would change the plan, and what uncertainty will remain. Complete removal, a single session or restoration of the exact appearance before filler cannot be guaranteed. B1 F1 G1

Options and follow-up

After assessment, the discussion may include monitoring a stable concern, targeted reduction of confirmed HA filler, or a different specialist plan. Persistent redness, tenderness or a draining lump needs medical assessment; additional injections should not be treated as the automatic answer. Removal procedures also carry risks. F1 F4

Agree on the intended extent of change and a follow-up point before treatment. Ask how the team will distinguish the original problem from temporary swelling, and what would justify another session. A small trial showing that hyaluronidase can reduce HA nodules does not predict your individual result. B1 F2 G1

Risks and warning signs

Hyaluronidase can cause local redness, swelling, itching or pain. Allergic reactions, including severe reactions, have been reported. Tell the clinician about prior reactions; do not assume that a previous uneventful injection rules out risk. F4

Difficulty breathing, throat or tongue swelling, or collapse after an injection requires emergency help. Contact emergency services immediately rather than waiting for the clinic to reply. New visual symptoms or concerning skin-colour changes after filler also need urgent assessment. F5 F1 F6

Frequently asked questions

Can every filler be dissolved?

No. Hyaluronidase acts on hyaluronic acid. Other materials need their own assessment and may be difficult or impossible to remove completely. F1 F2

Does ultrasound guarantee a safe or complete result?

No. It can provide useful information in selected cases, but cannot remove all risks or guarantee complete dissolution. Ask how the findings apply to your problem. B1 F3

Does swelling mean that filler must be dissolved?

Not necessarily. The cause needs assessment; inflammation or infection can require a different approach. Describe when swelling began and any associated pain or redness. F1 F4

How many sessions will I need?

That cannot be determined from a photograph or the name of a procedure. Product, location, symptoms and response matter; agree on reassessment rather than a guaranteed session count. B1 F2

What should I ask before agreeing?

Ask which product is thought to be present, what the proposed medicine is, the intended change, alternatives, risks and the plan if symptoms worsen. Request written follow-up and emergency contact information. B1 F4 G1